(171), six out of six patients with R/R B-ALL achieved MRD-negative CR after infusion of CD19/CD22 bispecific CAR T-cells, with one patient with mild CRS and no patient with NT. This evidence concerns the gene CD19 and acute lymphoblastic leukemia.